Chison Medical Technologies Future Growth
Future criteria checks 5/6
Chison Medical Technologies is forecast to grow earnings and revenue by 32.8% and 31.4% per annum respectively. EPS is expected to grow by 32.2% per annum. Return on equity is forecast to be 18.4% in 3 years.
Key information
32.8%
Earnings growth rate
32.2%
EPS growth rate
Medical Equipment earnings growth | 23.0% |
Revenue growth rate | 31.4% |
Future return on equity | 18.4% |
Analyst coverage | Low |
Last updated | 24 Apr 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,101 | 363 | 240 | 304 | 1 |
12/31/2025 | 983 | 292 | 146 | 240 | 2 |
12/31/2024 | 675 | 211 | 106 | 184 | 1 |
3/31/2024 | 459 | 140 | 79 | 109 | N/A |
12/31/2023 | 484 | 146 | 52 | 86 | N/A |
9/30/2023 | 428 | 122 | 47 | 82 | N/A |
6/30/2023 | 449 | 142 | 44 | 87 | N/A |
3/31/2023 | 446 | 134 | 34 | 77 | N/A |
12/31/2022 | 381 | 106 | 12 | 64 | N/A |
9/30/2022 | 463 | 160 | 16 | 65 | N/A |
6/30/2022 | 439 | 141 | 8 | 47 | N/A |
3/31/2022 | 417 | 115 | -5 | 32 | N/A |
12/31/2021 | 398 | 112 | 1 | 40 | N/A |
9/30/2021 | 403 | 112 | 26 | 69 | N/A |
6/30/2021 | 390 | 108 | 36 | 73 | N/A |
3/31/2021 | 348 | 105 | 35 | 83 | N/A |
12/31/2020 | 333 | 100 | 52 | 82 | N/A |
9/30/2020 | 351 | 110 | 34 | 55 | N/A |
6/30/2020 | 340 | 106 | 41 | 61 | N/A |
3/31/2020 | 386 | 117 | 56 | 67 | N/A |
12/31/2019 | 370 | 105 | 72 | 80 | N/A |
9/30/2019 | 354 | 101 | N/A | N/A | N/A |
12/31/2018 | 327 | 95 | 66 | 71 | N/A |
12/31/2017 | 272 | 64 | N/A | 62 | N/A |
12/31/2016 | 167 | 30 | N/A | 42 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688358's forecast earnings growth (32.8% per year) is above the savings rate (2.9%).
Earnings vs Market: 688358's earnings (32.8% per year) are forecast to grow faster than the CN market (23.3% per year).
High Growth Earnings: 688358's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688358's revenue (31.4% per year) is forecast to grow faster than the CN market (14.1% per year).
High Growth Revenue: 688358's revenue (31.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688358's Return on Equity is forecast to be low in 3 years time (18.4%).